Xolair Sales Data

Rank 82 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Xolair U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 82 (1) 1.91% -1.68%
Q3 2013 83 (5) 0.07%
Q2 2013 78 (15) 11.87% 7.97%
Q1 2013 93 (2) -0.33% -0.72%
Q4 2012 91 -0.81% -4.79%
Q3 2012 91 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
March 21, 2011Allergy Drug May Speed Up Kids' Ability to Tolerate Milk
July 17, 2009FDA Reviewing Preliminary Safety Information on Asthma Drug Xolair
July 16, 2009FDA Investigating Safety of Asthma Drug Xolair
Hide
(web5)